*ST金比(002762.SZ):預計半年度虧損800萬元–1600萬元
格隆匯7月11日丨*ST金比(002762.SZ)公佈,預計半年度營業收入16,000萬元–17,000萬元,比上年同期增長104.45%—117.23%,虧損800萬元–1,600萬元,扣非虧損800萬元–1,600萬元。
1、服務板塊業務:珠海韓妃醫療美容門診部有限公司、中山韓妃醫療美容門診部有限公司2025年1-6月營業收入合計約3,300萬元。2、產品板塊業務:公司加大電商渠道的投入,調整商品結構,帶動公司營收增長。3、受市場環境等多種因素影響,2025年上半年,公司參股的廣東韓妃醫院投資有限公司雖同比大幅度減虧,但仍有一定程度的虧損,根據企業會計準則,公司需按持股比例確認投資損失;2025年上半年,公司新升級IP形象逐步應用於產品、包裝等,對老產品加快促銷處理,回籠資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.